Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin-to-skin”

14,152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 14,152 results

Not applicableStudy completedNCT01894880
What this trial is testing

Pilot Study: Sectio Bonding/Early Skin-to-skin Contact (SSC) After Caesarean Section

Who this might be right for
Early Skin-to-skin Contact
Medical University of Graz 35
Testing effectiveness (Phase 2)Study completedNCT00428896
What this trial is testing

A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital of Crete 24
Large-scale testing (Phase 3)Study completedNCT01063062
What this trial is testing

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Early research (Phase 1)Study completedNCT03798561
What this trial is testing

Study to Evaluate ASN008 Topical Gel (TG)

Who this might be right for
Dermatitis, AtopicPruritusDermatitis Eczema
Asana BioSciences 24
Not applicableNot Yet RecruitingNCT07611305
What this trial is testing

ProGo Menopause Wellbeing Study

Who this might be right for
Menopause Related Conditions
Hofseth Biocare ASA 100
Not applicableStudy completedNCT01518205
What this trial is testing

HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F)

Who this might be right for
Foot UlcersArteriosclerosis ObliteransDiabetes Mellitus
Universita di Verona 13
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Large-scale testing (Phase 3)Study completedNCT04167462
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Who this might be right for
Psoriasis
Bristol-Myers Squibb 220
Not applicableStudy completedNCT04917146
What this trial is testing

Systemic Sclerosis' Relatives Reflex

Who this might be right for
Systemic SclerosisCaregivers
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT00458861
What this trial is testing

BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 115
Large-scale testing (Phase 3)Study completedNCT01257061
What this trial is testing

Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment

Who this might be right for
Eczema
EMS 310
Not applicableStudy completedNCT01725386
What this trial is testing

An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 274
Early research (Phase 1)Study completedNCT02914470
What this trial is testing

Carboplatin-cyclophosphamide Combined With Atezolizumab

Who this might be right for
Breast CancerCervix CancerOvarian Cancer+1 more
The Netherlands Cancer Institute 12
Large-scale testing (Phase 3)Looking for participantsNCT07207070
What this trial is testing

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Risen (Suzhou) Pharma Tech Co., Ltd. 312
Not applicableEnded earlyNCT05742269
What this trial is testing

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
Karolinska University Hospital 3
Large-scale testing (Phase 3)Study completedNCT04921969
What this trial is testing

Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

Who this might be right for
Atopic Dermatitis
Incyte Corporation 330
Large-scale testing (Phase 3)Ended earlyNCT00130494
What this trial is testing

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Who this might be right for
Breast CancerNeoplasm Metastasis
Spanish Breast Cancer Research Group 97
Early research (Phase 1)Looking for participantsNCT04872166
What this trial is testing

BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Who this might be right for
Advanced Solid TumorMetastatic Breast Cancer
Edgewood Oncology Inc. 112
Not applicableNot Yet RecruitingNCT06193122
What this trial is testing

Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 200
Next Page